- Home
- LSTA vs NUKK Comparison
LSTA vs NUKK Comparison
Compare LSTA & NUKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- NUKK
- Stock Information
- Founded
- LSTA 1980
- NUKK 2013
- Country
- LSTA United States
- NUKK United States
- Employees
- LSTA N/A
- NUKK N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- NUKK Blank Checks
- Sector
- LSTA Health Care
- NUKK Finance
- Exchange
- LSTA Nasdaq
- NUKK Nasdaq
- Market Cap
- LSTA 22.3M
- NUKK 25.4M
- IPO Year
- LSTA N/A
- NUKK N/A
- Fundamental
- Price
- LSTA $2.17
- NUKK $4.78
- Analyst Decision
- LSTA Strong Buy
- NUKK
- Analyst Count
- LSTA 2
- NUKK 0
- Target Price
- LSTA $23.50
- NUKK N/A
- AVG Volume (30 Days)
- LSTA 25.5K
- NUKK 9.9M
- Earning Date
- LSTA 08-07-2025
- NUKK 11-14-2025
- Dividend Yield
- LSTA N/A
- NUKK N/A
- EPS Growth
- LSTA N/A
- NUKK N/A
- EPS
- LSTA N/A
- NUKK N/A
- Revenue
- LSTA $1,070,000.00
- NUKK N/A
- Revenue This Year
- LSTA N/A
- NUKK N/A
- Revenue Next Year
- LSTA N/A
- NUKK N/A
- P/E Ratio
- LSTA N/A
- NUKK N/A
- Revenue Growth
- LSTA N/A
- NUKK N/A
- 52 Week Low
- LSTA $1.87
- NUKK $1.30
- 52 Week High
- LSTA $4.20
- NUKK $78.32
- Technical
- Relative Strength Index (RSI)
- LSTA 37.46
- NUKK 45.87
- Support Level
- LSTA $2.55
- NUKK $4.35
- Resistance Level
- LSTA $2.63
- NUKK $7.19
- Average True Range (ATR)
- LSTA 0.17
- NUKK 1.26
- MACD
- LSTA -0.04
- NUKK 0.26
- Stochastic Oscillator
- LSTA 17.86
- NUKK 18.75
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About NUKK Nukkleus Inc.
Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).